| Quote | Spy INO NEW ![]() |
Message Board | |||||
|
Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders. |
|
The $2000 Swine Flu Drug
BAX GILD BCRX APT RHHBY HEB DVAX INO SVA Linked by tickerspy blog - November 05, 09:53AM from (www.tickerspy.com) The peramivir pricing speculation is over, and the first order has been shipped. The U.S. FDA issued more ...
BioCryst takes on Tamiflu
VICL APT RHHBY HEB PURE INO SVA Linked by tickerspy blog - September 14, 11:43AM from (www.tickerspy.com) Peramivir could be the next swine flu-fighting one-dose wonder. BioCryst Pharmaceuticals (NADSAQ: BCRX) more ...
BIOTA - THE MOST UNDERVALUED FLU-STOCK OF THE WORLD !!
VICL BCRX NVAX INO SVA Posted by eric949 - August 29, 07:31AM Have a look at BIOTA HOLDINGS, imho this is THE MOST UNDERVALUED FLU STOCK IN THE WORLD !! Why ? more ...
Tools for the Swine Flu Investor
BAX GILD BCRX APT RHHBY INO NVS SNY GSK Linked by tickerspy blog - August 25, 10:13AM from (www.tickerspy.com) Various government officials are issuing recommendations for the upcoming flu season, but who is looking out for your portfolio? more ...
not yet approved
NVAX INO Posted by rfkcalif - August 24, 08:35PM Reading the news regarding NVAX isn't even approved by the FDA as well as most of the others. I also wrote the company of more ...
It's Not All Swine Flu for Vaccine Stocks
BCRX AZN HEB NVAX DVAX INO NVS SNY Linked by tickerspy blog - August 05, 11:43AM from (www.tickerspy.com) Vaccine stocks were mixed mid-week, some on flu-related news, others not. After the bell yesterday, more ...
Swine Flu Masks: Prevention or Placebo?
MMM AVII NVAX PURE INO GSK Linked by tickerspy blog - July 31, 10:43AM from (www.tickerspy.com) Companies are ramping up production of disposable surgical masks in anticipation of a fall swine flu outbreak, but the Centers more ...
Swine Flu Research Causes 165% Surge In Inovio
INO Linked by 24/7 Wall St. - July 29, 11:32AM from (feedproxy.google.com) As first reported at our affiliate site BioHealth Investor: Inovio Biomedical Corporation (NYSE Amex: INO) has been more ...
Inovio Biomedical Reports 4(th) Quarter and Year-End 2008 Financial Results
INO Linked by BusinessWire - March 31, 04:30PM from (www.businesswire.com) Inovio Biomedical Corporation (AMEX:INO) (“Inovio”) today reported financial results for the quarter and year more ...
DNA Vaccine Company Inovio Biomedical Reports Third Quarter 2008 Financial Results
INO Linked by BusinessWire - November 07, 05:19PM from (www.businesswire.com) Inovio Biomedical Corporation (AMEX:INO) (“Inovio”) today reported financial results for the three and more ...
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Home | About | Register | My tickerspy | Logout | Web site design by LightMix |
| © 2009 Indie Research, LLC. All rights reserved. | |
---
Institutional Holdings Disclaimer Pro portfolios track the top 15 quarterly holdings of more than 1,400 institutions. Comments in Pro portfolios show the institution's change in shares held for each company quarter over quarter. Pro portfolio performance is based on institutions' top 15 holdings as disclosed in quarter-end filings with the SEC. Pro performance does not take into account additional holdings beyond the top 15 nor does it include positions that are not required to be disclosed by the SEC. As such, Pro portfolio performance should be considered an approximation and not a precise record of how an institution has performed over time. tickerspy is not affiliated with any of the Pro investors profiled on our web site. The performance data and graph are estimates and do not represent an advertisement or endorsement by either tickerspy or the Pro investors. THE INFORMATION PROVIDED TO YOU HEREUNDER IS PROVIDED "AS IS" AND TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, INDIE RESEARCH, LLC AND IT LICENSORS, BUSINESS ASSOCIATES AND SUPPLIERS DISCLAIM ALL WARRANTIES WITH RESPECT TO THE SAME, EXPRESS, IMPLIED AND STATUTORY, INCLUDING WITHOUT LIMITATION ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, ACCURACY, COMPLETENESS AND NON-INFRINGEMENT. TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, NEITHER INDIE RESEARCH, LLC NOR ITS OFFICERS, MEMBERS, DIRECTORS, PARTNERS, AFFILIATES, BUSINESS ASSOCIATES, LICNESORS OR SUPPLIERS WILL BE LIABLE FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL OR PUNITIVE DAMAGES, INCLUDING WITHOUT LIMITATION DAMAGAES FOR LOST PROFITS OR REVENUES, GOODWILL, WORK STOPPAGE, SECURITY BREACHES, VIRUSES, COMPUTER FAILURE OR MALFUNCTION, USE, DATA OR OTHER INTANGIBLE LOSSES OR COMMERCIAL DAMAGES, EVEN IF ANY OF SUCH PARTIES ADVISED OF THE POSSIBILITY OF SUCH LOSSES, ARISING UNDER OR IN CONNECTION WITH THE INFORMATION PROVIDED HEREIN OR ANY OTHER SUBJECT MATTER HEREOF. |
|